Cipla, Pfizer ink partnership for exclusive marketing of four brands in India
Pharmaceutical companies Pfizer India and Cipla Limited today announced a partnership where Cipla will exclusively market and distribute four key brands of Pfizer in India. Under the agreement, Cipla now has the sole right to market, distribute and sell the cough syrup- Corex Dx and Corex LS, the non-steroidal anti-inflammatory drug (NSAID) Dolonex, the proton…
